Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026)
Aytu Biopharma's (AYTU) Asset Utilization Ratio was 0.53 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 0.6% from 0.53 a year earlier but up 9.7% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Asset Utilization Ratio at Aytu Biopharma was 0.50, down 8.3% from FY2025.
- By fiscal year, Asset Utilization Ratio came in at 0.55 in FY2025 (+7.0%), 0.51 in FY2024 (-34.7%), 0.78 in FY2023 (+63.5%) and 0.48 in FY2022 (+53.0%).
- Five-year quarterly Asset Utilization Ratio spans a low of 0.30 in fiscal Q1 2022 and a high of 0.76 in fiscal Q4 2023.
- Year over year, Asset Utilization Ratio has now declined in each of the last four quarters, with an average decline of 10.1% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was fiscal Q4 2022 (growth of 158.2%); the low point was fiscal Q4 2024 (a decline of 30.3%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at 0.48 (Q3 2026), 0.51 (Q2 2026) and 0.51 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 0.31 |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 0.53 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.53 |
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.51 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.72 |
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.72 |
| Sep 30, 2022 | 0.71 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.47 |
| Dec 31, 2021 | 0.36 |
| Sep 30, 2021 | 0.30 |
API Access
Aytu Biopharma Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();